Moreover, Kaplan‒Meier analyses of public datasets revealed that high LCN2 mRNA levels predict worse event-free survival (EFS) (Fig. 1h) and overall survival (OS) in lung cancer patients (Fig. 1i). This evidence concerns the gene LCN2 and lung carcinoma.